Penumbra Inc (PEN) - Total Liabilities

Latest as of March 2026: $424.63 Million USD

Based on the latest financial reports, Penumbra Inc (PEN) has total liabilities worth $424.63 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Penumbra Inc - Total Liabilities Trend (2013–2025)

This chart illustrates how Penumbra Inc's total liabilities have evolved over time, based on quarterly financial data. See PEN working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Penumbra Inc Competitors by Total Liabilities

The table below lists competitors of Penumbra Inc ranked by their total liabilities.

Company Country Total Liabilities
ARC Resources Ltd.
TO:ARX
Canada CA$5.88 Billion
iA Financial Corporation Inc
TO:IAG
Canada CA$117.74 Billion
Nanya New Material Technology Co Ltd
SHG:688519
China CN¥3.95 Billion
Graco Inc
NYSE:GGG
USA $592.37 Million
GAIL (India) Limited
NSE:GAIL
India Rs480.58 Billion
Yunnan Baiyao Group Co Ltd
SHE:000538
China CN¥13.53 Billion
China Spacesat Co Ltd
SHG:600118
China CN¥5.25 Billion
United States Steel Corporation
NYSE:X
USA $4.08 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Penumbra Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Penumbra Inc market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 6.02 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.29 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.22 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Penumbra Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Penumbra Inc (2013–2025)

The table below shows the annual total liabilities of Penumbra Inc from 2013 to 2025.

Year Total Liabilities Change
2025-12-31 $398.92 Million +4.36%
2024-12-31 $382.25 Million +1.30%
2023-12-31 $377.36 Million +1.43%
2022-12-31 $372.03 Million +28.14%
2021-12-31 $290.32 Million +56.77%
2020-12-31 $185.19 Million +2.72%
2019-12-31 $180.29 Million +94.71%
2018-12-31 $92.59 Million +21.42%
2017-12-31 $76.26 Million +82.84%
2016-12-31 $41.71 Million +33.14%
2015-12-31 $31.33 Million -76.58%
2014-12-31 $133.75 Million +68.86%
2013-12-31 $79.21 Million --

About Penumbra Inc

NYSE:PEN USA Medical Devices
Market Cap
$12.44 Billion
Market Cap Rank
#1906 Global
#708 in USA
Share Price
$316.36
Change (1 day)
-0.40%
52-Week Range
$225.54 - $359.40
All Time High
$359.40
About

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombecto… Read more